Evidence map›Paper›PMID 37073963›Full record

ArticleActa dermato-venereologica2023

Drug Survival of Anti Interleukin-17 and Interleukin -23 Agents after Adalimumab Failure in Hidradenitis Suppurativa: A Pilot Study.

Federica Repetto, Gabriele Roccuzzo, Lorenza Burzi, Luca Mastorino, Paolo Dapavo, Pietro Quaglino, Simone Ribero

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta dermato-venereologica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Federica RepettoDepartment of Medical Sciences, Section of Dermatology, University of Turin, Via Cherasco 23, 10126, Turin, Italy.
Gabriele RoccuzzoDepartment of Medical Sciences, Section of Dermatology, University of Turin, Via Cherasco 23, 10126, Turin, Italy. gabriele.roccuzzo@unito.it.
Lorenza BurziDepartment of Medical Sciences, Section of Dermatology, University of Turin, Via Cherasco 23, 10126, Turin, Italy.
Luca MastorinoDepartment of Medical Sciences, Section of Dermatology, University of Turin, Via Cherasco 23, 10126, Turin, Italy.
Paolo DapavoDepartment of Medical Sciences, Section of Dermatology, University of Turin, Via Cherasco 23, 10126, Turin, Italy.
Pietro QuaglinoDepartment of Medical Sciences, Section of Dermatology, University of Turin, Via Cherasco 23, 10126, Turin, Italy.
Simone RiberoDepartment of Medical Sciences, Section of Dermatology, University of Turin, Via Cherasco 23, 10126, Turin, Italy.
University of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hidradenitis SuppurativaAdalimumabAnti-Inflammatory AgentsHumansPilot ProjectsAdalimumabAnti-Inflammatory Agents

Identifiers

PMID37073963
PMCPMC10128147
OpenAlexW4366350968

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.